A prospective study of prognostic value of type IV collagenase activity in colorectal cancer tissue

被引:12
作者
Ambiru, S
Miyazaki, M
Ito, H
Nakagawa, K
Shimizu, H
Nukui, Y
Nozawa, S
Okuno, A
Yoshitomi, H
Nakajima, N
机构
[1] First Department of Surgery, Chiha University, School of Medicine, Chuo-ku, Chiba
[2] First Department of Surgery, Chiba University, School of Medicine, Chuo-ku, Chiba 260
关键词
colorectal cancer; prognostic factor; type IV collagenase;
D O I
10.1023/A:1018801229372
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of this prospective study was to evaluate the prognostic value of the type IV collagenase (IVase) activity in colorectal cancer tissue on disease-free and overall survival in 31 colorectal cancer patients. The clinicopathologic factors studied for prognostic value were age, tumor location, tumor differentiation; preoperative serum levels of carcinoembryonic antigen, Dukes' stage, and IVase activity in colorectal cancer tissue. IVase activities in colorectal cancer tissue were significantly higher in the group of patients with recurrences than in the group without recurrences (P = 0.019). Patients with high IVase activity in colorectal dancer tissue had a significantly shorter disease-free survival (P = 0.0016) and overall survival (P = 0.022) time than those with low IVase activity. Univariate and multivariate analysis showed that significant prognostic factors for disease-free survival were Dukes' stage (P = 0.029, P = 0.046, respectively) and IVase activity status (P = 0.0016, P = 0.0026, respectively). With respect to overall survival, only IVase activity status provided significant Predictive value in multivariate analysis (P = 0.041). This prospective study suggests that IVase activity is a valuable prognostic factor in colorectal cancer patients.
引用
收藏
页码:1660 / 1665
页数:6
相关论文
共 38 条
[21]   SUPPRESSION OF THE TUMORIGENIC AND METASTATIC ABILITIES OF MURINE B16-F10 MELANOMA-CELLS IN-VIVO BY THE OVEREXPRESSION OF THE TISSUE INHIBITOR OF THE METALLOPROTEINASES-1 [J].
KHOKHA, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (04) :299-304
[22]  
KUBOCHI K, 1986, PROTEINASES INFLAMMA, P337
[23]  
LEVY AT, 1991, CANCER RES, V51, P439
[24]  
Liabakk NB, 1996, CANCER RES, V56, P190
[25]   PARTIAL-PURIFICATION AND CHARACTERIZATION OF A NEUTRAL PROTEASE WHICH CLEAVES TYPE-IV COLLAGEN [J].
LIOTTA, LA ;
TRYGGVASON, K ;
GARBISA, S ;
ROBEY, PG ;
ABE, S .
BIOCHEMISTRY, 1981, 20 (01) :100-104
[26]  
LIOTTA LA, 1983, LAB INVEST, V49, P636
[27]  
LIOTTA LA, 1986, CANCER RES, V46, P1
[28]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[29]   DIRECT MEASUREMENT OF NEUTRAL COLLAGENASE ACTIVITY IN HOMOGENATES FROM BABOON AND HUMAN-LIVER [J].
MARUYAMA, K ;
FEINMAN, L ;
OKAZAKI, I ;
LIEBER, CS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 658 (01) :124-131
[30]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND OUTCOME IN DUKES B-COLORECTAL-CANCER [J].
MULCAHY, HE ;
DUFFY, MJ ;
GIBBONS, D ;
MCCARTHY, P ;
PARFREY, NA ;
ODONOGHUE, DP ;
SHEAHAN, K .
LANCET, 1994, 344 (8922) :583-584